Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release

Journal of Controlled Release

Volumn 105, Issue 3, 2005, Pages 344-353

  Kunisawa, Jun ^a   Masuda, Takashi ^a   Katayama, Kazufumi ^a   Yoshikawa, Tomoaki ^a,b   Tsutsumi, Yasuo ^a,b   Akashi, Mitsuru ^b,c   Mayumi, Tadanori ^a   Nakagawa, Shinsaku ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotide DNA; Drug delivery; Fusogenic liposome; Nanoparticle; Nanotechnology

Indexed keywords

CYTOLOGY; DNA; GENETIC ENGINEERING; OLIGOMERS; PHARMACOKINETICS; REACTION KINETICS; RNA;

CYTOTOXICITY; FUNCTIONAL NANOPARTICLES; OLIGONUCLEOTIDES; RNA INTERFERENCE;

CONTROLLED DRUG DELIVERY;

ALPHA DIMYRISTOYLPHOSPHATIDIC ACID; AMINE; CHOLESTEROL; DNA; LIPOSOME; NANOPARTICLE; OLIGONUCLEOTIDE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; POLY(VINYLAMINE); UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENCAPSULATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SENDAI VIRUS; ULTRAVIOLET RADIATION; VIRUS INACTIVATION;

ANIMALS; CELL LINE, TUMOR; CYTOSOL; DRUG CARRIERS; DRUG COMPOUNDING; EXCIPIENTS; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; LIPOSOMES; LLC-PK1 CELLS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGONUCLEOTIDES; POLYVINYL CHLORIDE; SENDAI VIRUS; SWINE;

EID: 21744448804     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.03.020     Document Type: Article

References (35)

1. D.A. LaVan, D.M. Lynn, and R. Langer Moving smaller in drug discovery and delivery Nat. Rev. Drug Discov. 1 1 2002 77 84
2. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 5 2003 347 360
3. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 3 2003 403 419
4. R.M. Schek, S.J. Hollister, and P.H. Krebsbach Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy Molec. Ther. 9 1 2004 130 138
5. M.E. Akerman, W.C. Chan, P. Laakkonen, S.N. Bhatia, and E. Ruoslahti Nanocrystal targeting in vivo Proc. Natl. Acad. Sci. U. S. A. 99 20 2002 12617 12621
6. J. Alper Drug delivery. Breaching the membrane Science 296 5569 2002 838 839
7. J.B. Opalinska, and A.M. Gewirtz Nucleic-acid therapeutics: basic principles and recent applications Nat. Rev. Drug Discov. 1 7 2002 503 514
8. Y.S. Cho-Chung Antisense DNAs as targeted genetic medicine to treat cancer Arch. Pharm. Res. 26 3 2003 183 191
9. T. Suwanmanee, H. Sierakowska, S. Fucharoen, and R. Kole Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder Molec. Ther. 6 6 2002 718 726
10. N.R. Wall, and Y. Shi Small RNA: can RNA interference be exploited for therapy? Lancet 362 9393 2003 1401 1403
11. E. Song, S.K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar, and J. Lieberman RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 9 3 2003 347 351
12. J. Kunisawa, S. Nakagawa, and T. Mayumi Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development Adv. Drug Deliv. Rev. 52 3 2001 177 186
13. N. Murthy, M. Xu, S. Schuck, J. Kunisawa, N. Shastri, and J.M. Frechet A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels Proc. Natl. Acad. Sci. U. S. A. 100 9 2003 4995 5000
14. M.C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19 12 2001 1173 1176
15. E. Mathew, G.E. Hardee, C.F. Bennett, and K.D. Lee Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes Gene Ther. 10 13 2003 1105 1115
16. H. Mizuguchi, T. Nakagawa, M. Nakanishi, S. Imazu, S. Nakagawa, and T. Mayumi Efficient gene transfer into mammalian cells using fusogenic liposome Biochem. Biophys. Res. Commun. 218 1 1996 402 407
17. H. Mizuguchi, T. Nakagawa, S. Toyosawa, M. Nakanishi, S. Imazu, T. Nakanishi, Y. Tsutsumi, S. Nakagawa, T. Hayakawa, N. Ijuhin, and T. Mayumi Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors Cancer Res. 58 24 1998 5725 5730
18. H. Mizuguchi, M. Nakanishi, T. Nakanishi, T. Nakagawa, S. Nakagawa, and T. Mayumi Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy Br. J. Cancer 73 4 1996 472 476
19. T. Nakanishi, A. Hayashi, J. Kunisawa, Y. Tsutsumi, K. Tanaka, Y. Yashiro-Ohtani, M. Nakanishi, H. Fujiwara, T. Hamaoka, and T. Mayumi Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway Eur. J. Immunol. 30 6 2000 1740 1747
20. A. Hayashi, T. Nakanishi, J. Kunisawa, M. Kondoh, S. Imazu, Y. Tsutsumi, K. Tanaka, H. Fujiwara, T. Hamaoka, and T. Mayumi A novel vaccine delivery system using immunopotentiating fusogenic liposomes Biochem. Biophys. Res. Commun. 261 3 1999 824 828
21. J. Kunisawa, T. Nakanishi, I. Takahashi, A. Okudaira, Y. Tsutsumi, K. Katayama, S. Nakagawa, H. Kiyono, and T. Mayumi Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system J. Immunol. 167 3 2001 1406 1412
22. G. Sakaue, T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses J. Immunol. 170 1 2003 495 502
23. K. Yachi, H. Harashima, H. Kikuchi, R. Sudo, H. Yamauchi, K. Ebihara, H. Matsuo, K. Funato, and H. Kiwada Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug Biopharm. Drug Dispos. 17 7 1996 589 605
24. S. Sakuma, N. Suzuki, R. Sudo, K. Hiwatari, A. Kishida, and M. Akashi Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin Int. J. Pharm. 239 1-2 2002 185 195
25. N. Pante, and M. Kann Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm Mol. Biol. Cell 13 2 2002 425 434
26. Z. Shen, G. Reznikoff, G. Dranoff, and K.L. Rock Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules J. Immunol. 158 6 1997 2723 2730
27. M. Nakanishi, H. Mizuguchia, K. Ashihara, T. Senda, T. Akuta, J. Okabe, E. Nagoshi, A. Masago, A. Eguchi, Y. Suzuki, H. Inokuchi, A. Watabe, S. Ueda, T. Hayakawa, and T. Mayumi Gene transfer vectors based on Sendai virus J. Control. Release 54 1 1998 61 68
28. D.P. Howell, R.J. Krieser, A. Eastman, and M.A. Barry Deoxyribonuclease II is a lysosomal barrier to transfection Molec. Ther. 8 6 2003 957 963
29. C.M. Wiethoff, and C.R. Middaugh Barriers to nonviral gene delivery J. Pharm. Sci. 92 2 2003 203 217
30. Y. Ogawa Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs J. Biomater. Sci., Polym. Ed. 8 5 1997 391 409
31. S.B. La, T. Okano, and K. Kataoka Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl l-aspartate) block copolymer micelles J. Pharm. Sci. 85 1 1996 85 90
32. J. Kunisawa, A. Okudaira, Y. Tsutusmi, I. Takahashi, T. Nakanishi, H. Kiyono, and T. Mayumi Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses Vaccine 19 4-5 2000 589 594
33. J. Panyam, W.Z. Zhou, S. Prabha, S.K. Sahoo, and V. Labhasetwar Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J. 16 10 2002 1217 1226
34. V.P. Torchilin, R. Rammohan, V. Weissig, and T.S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. U. S. A. 98 15 2001 8786 8791
35. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G.G. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. U. S. A. 100 4 2003 1972 1977